[1] 郑雪玲.人脐血干细胞移植联合前列腺素E1治疗肝硬化的临床观察.临床和实验医学杂志,2016,15:650-653. [2] 薛顺和,袁东红,王芳,等.肝硬化患者并发感染及 死亡与肠道通透性实验检测的相关性研究.现代检验医学杂志,2017,32:95-98,102 [3] Aargenti K, Prytz H, Nilsson E, et al. Predictors of mortality among patients with compensated and decompensated liver cirrhosis:the role of bacterial infections and infection-related acute-on-chronic liver failure. Scand J Gastroenterol,2015,50:875-883. [4] 陈霞,俞莹莹,戴再友,等.乙型肝炎肝硬化患者医院获得性感染的危险因素分析及 ImmuKnow 法监测免疫细胞功能的价值.中华肝脏病杂志,2017,25:41-43. [5] 中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南(2010年版).中国肝脏病杂志(电子版),2011,16:113-128. [6] 崔宏,高琴琴,杨楠木,等.肝硬化患者腹腔感染的病原菌分布与耐药性分析.中华医院感染学杂志,2018,28:40-43. [7] 梁丽芬,周召刚,雷宇,等.154例肝硬化失代偿期患者并发血流感染的临床分析.中国感染与化疗杂志,2016,16:262-266. [8] Murphy EJ. Blood-brain barrier and brain fatty acid uptake: role of arachidonic acid and PGE2.J Neurochem,2015,135:845-848. [9] 王大刚,朱剑功,华菲,等.多指标联合检测在肝硬化合并感染诊断中的价值.第二军医大学学报,2015,36:1148-1151. [10] Brien AJ, Fullerton JN, Massey KA, et al. lmmunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2.Nat Med,2014,20:518-523. [11] 张鞠玲,耿伟,崔恩博,等.肝硬化合并自发性细菌性腹膜炎病原学特征分析.临床肝胆病杂志,2015,31:407-412. [12] Schlagenhauf A, Haidl H, Leschnik B,et al. Prostaglandin E2 levels and platelet function are different in cord blood compared to adults.Thromb Haemost,2015,113:97-106. [13] Gbel T, Schadewaldt-Tümmers J, Greiner L, et al. Transient elastography improves detection of liver cirrhosis compared to routine screening tests.World J Gastroenterol,2015,21:953-960. [14] 黄小平,王艳,孙蔚,等.失代偿期肝硬化患者血清中前列腺素E2水平对感染的预测价值研究.上海交通大学学报(医学版),2016,36:992-995. [15] 王丽,王鹏,尚娟.失代偿期肝硬化患者血清降钙素原和前列腺素E2水平变化与感染的关系研究.实用预防医学,2017,24:1388-1390. |